Shenzhen, China

Weiyue Chen

This inventor holds 1 USPTO granted patent and 11 published patent applications. Top assignee: Genemind Biosciences Company Limited. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weiyue Chen: Innovator in Biosciences

Introduction

Weiyue Chen is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biosciences, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the scientific community.

Latest Patents

Weiyue Chen holds a patent for a "Modified Klenow Fragment and Application Thereof." This invention showcases his ability to enhance existing technologies and contribute to advancements in genetic research. The patent reflects his commitment to innovation and the development of new methodologies in biosciences. He has 1 patent to his name.

Career Highlights

Weiyue Chen is currently employed at Genemind Biosciences Company Limited, where he continues to push the boundaries of scientific research. His work at Genemind focuses on developing cutting-edge solutions that address complex biological challenges. His career is marked by a strong dedication to improving health outcomes through innovative technologies.

Collaborations

Throughout his career, Weiyue Chen has collaborated with talented individuals such as Qingbin Chen and Hongdan Li. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Weiyue Chen is a notable inventor whose contributions to biosciences are shaping the future of genetic research. His innovative spirit and collaborative efforts continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…